Epithelial defensins impair adenoviral infection: implication for adenovirus-mediated gene therapy
about
Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trialsImpact of vitamin D on infectious diseaseAn intrinsically disordered region of the adenovirus capsid is implicated in neutralization by human alpha defensin 5The structure of human beta-defensin-1: new insights into structural properties of beta-defensinsVitamin D and extra-skeletal health: causality or consequenceIdentification of murine and human XCP1 genes as C/EBP-epsilon-dependent members of FIZZ/Resistin gene familySerum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adultsInsight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralizationEnhanced surfactant protein and defensin mRNA levels and reduced viral replication during parainfluenza virus type 3 pneumonia in neonatal lambsHuman alpha defensin 5 expression in the human kidney and urinary tractInhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1.Human alpha-defensins block papillomavirus infectionInnate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection.Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity.In vitro studies on the antimicrobial peptide human beta-defensin 9 (HBD9): signalling pathways and pathogen-related response (an American Ophthalmological Society thesis).High level expression of human epithelial beta-defensins (hBD-1, 2 and 3) in papillomavirus induced lesions.Implications of the innate immune response to adenovirus and adenoviral vectors.Viruses and the Microbiota.CXC chemokines and antimicrobial peptides in rhinovirus-induced experimental asthma exacerbations.Defensins and other antimicrobial peptides at the ocular surfaceAntimicrobial characterization of human beta-defensin 3 derivatives.Innate immune response to adenovirus.Peptide antimicrobial agents.Differential expression pattern of genes encoding for anti-microbial peptides in the fetal membranes of patients with spontaneous preterm labor and intact membranes and those with preterm prelabor rupture of the membranesAntiviral responses of human Fallopian tube epithelial cells to toll-like receptor 3 agonist poly(I:C).Cationic host defence peptides: potential as antiviral therapeuticsHost defense peptides in the oral cavity and the lung: similarities and differences.Defensins in viral infections.Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entryInnate host barriers to viral trafficking and population diversity: lessons learned from poliovirus.Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides.Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer.Integrin and defensin modulate the mechanical properties of adenovirus.Defensin production by human limbo-corneal fibroblasts infected with mycobacteriaHuman alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells.Modulation of human beta-defensin-1 (hBD-1) in plasmacytoid dendritic cells (PDC), monocytes, and epithelial cells by influenza virus, Herpes simplex virus, and Sendai virus and its possible role in innate immunity.The intestinal microbiota and viral susceptibility.Towards the Application of Human Defensins as Antivirals.Expression of Human ß-Defensin 1 mRNA in Human Palatine TonsilExpression of Human ß-defensin 1 mRNA in Human Nasal Mucosa
P2860
Q24634794-A2436135-9A83-4058-9C05-994F61E988AEQ27000724-F22AC125-F7CE-4319-8F92-FD6BFB2629FDQ27324472-547CA2DF-DB8A-491F-A9D3-CAE6F408223DQ27633872-15D59B7E-FA27-4703-82AC-5C1415131998Q28066698-B290EC52-595A-4295-BFE6-674A95863D44Q28507207-FC4C20EB-71C9-496F-8501-B2675D5AAA24Q33608637-1EC9AA6E-AFB8-4213-AFBC-9A4970859409Q33619244-5967C756-C267-4210-BB03-882BBBC6D55EQ33711962-C7467D7E-F574-4DED-8CC2-9C2B635A4C5DQ34168341-A35C8414-ABE6-4A72-9506-B9D77896C499Q34259967-6D085378-DBF3-4A32-B71D-DB240E98D198Q34334899-01F08494-B615-46B4-874D-EB76057133C7Q34339797-4248445F-D4E6-4C73-A079-54B954FDB7DBQ34758057-0E67F320-0126-4B40-9E2A-A23AA448E425Q35030919-F7F3C4DC-1F30-4134-B287-3A5F5A906404Q35053352-EFB2645F-F904-41B2-B38E-FDCBCC08214EQ35085363-409B9DC2-7FB6-49E3-87DB-A737690FECACQ35216531-DF879FE0-D253-4902-BD96-293EFD9FA09AQ35495112-8D5BAA26-3D9C-4643-93AD-70B1C924FA0DQ35594084-0F089617-7D43-4858-AD80-057A5157139EQ35685623-C716AEFC-D3CC-4A9E-9567-88552391DF9CQ36278163-984F33A9-6264-492B-9447-61451DA3FBFAQ36538861-C52F070C-F775-4A5F-AA5E-E897386F1947Q36578019-3D862BDE-1380-4A99-9E7F-4112DB56B285Q37108085-F1485168-EF89-4245-9683-8D925AC94AC3Q37177085-1073804C-8A60-47CA-80FC-49809A35915FQ37276479-F55637E3-EB25-4DE4-B95E-D5B7F77ABB8FQ37726739-FC9D1753-6A4D-4B6A-BC88-E8333AE556F2Q37730271-B0B077DD-8F5B-4DF1-97E9-D110F97BABF8Q37800652-078872CB-6A14-44B2-880C-9AF3CE9F1F6BQ38160482-44EDE019-62C2-4F77-B76A-57B2D63DA811Q38359636-7F025E4B-15A3-4CB6-9EE0-3FA4B2EEADF2Q39220443-F9007F6B-B283-4CEA-84E0-4BF3FB3815A4Q42469099-F5F9E226-FE16-4F4B-AF18-968706617CB6Q42708917-AE14C464-94D9-4DA2-888E-06B35F490503Q42793707-59D5407F-8CB7-4947-B16D-63F623EDA978Q42860414-AE45CEBF-A608-468B-9B2F-102FD15F13B3Q47557198-27D4224B-66A1-447B-8BF8-04628B47A188Q58081031-94B35D0D-9926-4980-B36B-D7B08A42E538Q58259221-5BFDC3C4-95A9-4CDD-A4FE-D09629A90B56
P2860
Epithelial defensins impair adenoviral infection: implication for adenovirus-mediated gene therapy
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Epithelial defensins impair ad ...... enovirus-mediated gene therapy
@ast
Epithelial defensins impair ad ...... enovirus-mediated gene therapy
@en
Epithelial defensins impair ad ...... enovirus-mediated gene therapy
@nl
type
label
Epithelial defensins impair ad ...... enovirus-mediated gene therapy
@ast
Epithelial defensins impair ad ...... enovirus-mediated gene therapy
@en
Epithelial defensins impair ad ...... enovirus-mediated gene therapy
@nl
prefLabel
Epithelial defensins impair ad ...... enovirus-mediated gene therapy
@ast
Epithelial defensins impair ad ...... enovirus-mediated gene therapy
@en
Epithelial defensins impair ad ...... enovirus-mediated gene therapy
@nl
P1433
P1476
Epithelial defensins impair ad ...... enovirus-mediated gene therapy
@en
P2093
P304
P356
10.1089/10430349950018355
P407
P577
1999-04-10T00:00:00Z